Historical Valuation
Diversified Healthcare Trust (DHC) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.38 is considered Undervalued compared with the five-year average of -2.90. The fair price of Diversified Healthcare Trust (DHC) is between 17.24 to 18.66 according to relative valuation methord. Compared to the current price of 5.92 USD , Diversified Healthcare Trust is Undervalued By 65.66%.
Relative Value
Fair Zone
17.24-18.66
Current Price：5.92
65.66%
Undervalued
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Diversified Healthcare Trust (DHC) has a current Price-to-Book (P/B) ratio of 0.00. Compared to its 3-year average P/B ratio of 0.32 , the current P/B ratio is approximately -100.00% higher. Relative to its 5-year average P/B ratio of 0.32, the current P/B ratio is about -100.00% higher. Diversified Healthcare Trust (DHC) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of 15.71%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of 15.71% , the current FCF yield is about -100.00% lower.
Competitors Valuation Multiple
AI Analysis
The average P/S ratio for DHC competitors is 3.62, providing a benchmark for relative valuation. Diversified Healthcare Trust Corp (DHC.O) exhibits a P/S ratio of 0.38, which is -89.49% above the industry average. Given its robust revenue growth of 4.34%, this premium appears unsustainable.
Performance Decomposition
AI Analysis
1Y
3Y
5Y
Market capitalization of DHC increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of DHC in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is DHC currently overvalued or undervalued?
Diversified Healthcare Trust (DHC) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.38 is considered Undervalued compared with the five-year average of -2.90. The fair price of Diversified Healthcare Trust (DHC) is between 17.24 to 18.66 according to relative valuation methord. Compared to the current price of 5.92 USD , Diversified Healthcare Trust is Undervalued By 65.66% .
What is Diversified Healthcare Trust (DHC) fair value?
DHC's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Diversified Healthcare Trust (DHC) is between 17.24 to 18.66 according to relative valuation methord.
How does DHC's valuation metrics compare to the industry average?
The average P/S ratio for DHC's competitors is 3.62, providing a benchmark for relative valuation. Diversified Healthcare Trust Corp (DHC) exhibits a P/S ratio of 0.38, which is -89.49% above the industry average. Given its robust revenue growth of 4.34%, this premium appears unsustainable.
What is the current P/B ratio for Diversified Healthcare Trust (DHC) as of Jan 17 2026?
As of Jan 17 2026, Diversified Healthcare Trust (DHC) has a P/B ratio of 0.00. This indicates that the market values DHC at 0.00 times its book value.
What is the current FCF Yield for Diversified Healthcare Trust (DHC) as of Jan 17 2026?
As of Jan 17 2026, Diversified Healthcare Trust (DHC) has a FCF Yield of 0.00%. This means that for every dollar of Diversified Healthcare Trust’s market capitalization, the company generates 0.00 cents in free cash flow.
What is the current Forward P/E ratio for Diversified Healthcare Trust (DHC) as of Jan 17 2026?
As of Jan 17 2026, Diversified Healthcare Trust (DHC) has a Forward P/E ratio of -2.89. This means the market is willing to pay $-2.89 for every dollar of Diversified Healthcare Trust’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Diversified Healthcare Trust (DHC) as of Jan 17 2026?
As of Jan 17 2026, Diversified Healthcare Trust (DHC) has a Forward P/S ratio of 0.38. This means the market is valuing DHC at $0.38 for every dollar of expected revenue over the next 12 months.